sirolimus and benzylguanidine

sirolimus has been researched along with benzylguanidine* in 1 studies

Other Studies

1 other study(ies) available for sirolimus and benzylguanidine

ArticleYear
Reversible Chemical Dimerization by rCD1.
    Methods in enzymology, 2017, Volume: 583

    An optimal tool to unravel the role of a specific player within a cellular network or process requires its spatiotemporally resolved perturbation. Chemically induced dimerization (CID) by the rapamycin system has proven useful to induce protein dimerization or translocation with high spatiotemporal precision. Recently, we and others have added reversibility of the dimerization event as a novel feature to CID approaches. Among those, our reversible chemical dimerizer (rCD1) shows the fastest release kinetics observed, comparable to optogenetic methods. Induction and termination of enzyme activities, including phosphatidylinositol 3-kinase (PI3K) and 5-phosphatase (5Ptase), therefore allowed us to monitor the relaxation of the downstream effectors within living cells by imaging and traditional biochemical methods. Because switching off the rCD1-induced enzyme activity is sufficiently fast, it is possible to estimate kinetic parameters for enzyme activity and metabolism. Fast reversible CIDs are therefore unique tools for performing semiquantitative biochemistry in intact cells. In this chapter, we discuss advantages and constraints for the design of reversible CID applications. We provide detailed protocols for rCD1 synthesis, CID component expression in and delivery to mammalian cells and the determination of enzyme kinetics inside intact cells by a specially designed image acquisition and data analysis method.

    Topics: Animals; Binding Sites; Binding, Competitive; Calcineurin Inhibitors; Gene Expression; Guanidines; HeLa Cells; Humans; Kinetics; Phosphatidylinositol 3-Kinases; Phosphoric Monoester Hydrolases; Protein Binding; Protein Multimerization; Protein Transport; Recombinant Fusion Proteins; Sirolimus; src Homology Domains; Tacrolimus; Tacrolimus Binding Proteins

2017